ADORA1
MOLECULAR TARGETadenosine A1 receptor
ADORA1 (adenosine A1 receptor) is targeted by 14 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting ADORA1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | 2-Chloroadenosine 2-Chloroadenosine. | 2.94 | 18 |
| 2 | Adenosine | 2.20 | 8 |
| 3 | Caffeine | 1.10 | 2 |
| 4 | Genistein | 1.10 | 2 |
| 5 | Luteolin 5,7,3',4'-tetrahydroxy-flavone, | 1.10 | 2 |
| 6 | Apigenin 5,7,4'-trihydroxy-flavone, | 0.69 | 1 |
| 7 | Quercetin | 0.69 | 1 |
| 8 | Cladribine | 0.69 | 1 |
| 9 | Clofarabine | 0.69 | 1 |
| 10 | hispidol | 0.69 | 1 |
| 11 | Nitrendipine | 0.69 | 1 |
| 12 | Pentostatin | 0.69 | 1 |
| 13 | Rifaximin | 0.69 | 1 |
| 14 | Triiodothyronine | 0.69 | 1 |
About ADORA1 as a Drug Target
ADORA1 (adenosine A1 receptor) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 14 compounds with documented ADORA1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
ADORA1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.